Citations

Clear

432 citation(s) found for "Schroeder, L".

“I Just Want People to See Me as a Decent Human Being”: Perceptions of Screening Mammography in an Underserved Group
Cathcart-Rake, Elizabeth , Fee-Schroeder, Kelliann C., Looney, Sandy M., Phelan, Lynn M., Herndon, Justine , Olswold, Tiffany M, Oldham, Emmett E, Fonseca, Emrys , Stephenson, Noreen

Mayo Clinic

Journal of the National Comprehensive Cancer Network | October 6, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.6004/jnccn.2026.7050 | PMID 42838084 Get It

Background: This qualitative study sought to understand factors related to low rates of screening mammography among transgender and gender-diverse (TGD) individuals and how these rates might be improved. Methods: Individuals who self-reported as TGD were recruited from multiple sites and national patient advocates. Consenting participants completed an individual interview using a semistructured guide informed by the Health Belief Model (HBM). Interview data were analyzed using thematic analysis. Results: A total of 44 individuals completed the interview (median age, 44.9 years; range, 19–77 years); 11% were a racial/ethnic minority; and 52%, 20%, and 25%, respectively, self-identified as a transgender woman, transgender man, or nonbinary. Three themes emerged around constructs in the HBM. First, individuals voiced a hope to be treated equally (“I just want to go to work, pay my taxes, love my family, and go along my day and be a good human”) and described how such equitable treatment during screening guarded against gender dysphoria and favored gender affirmation (“it is affirming…being treated as any other woman”). Second, barriers and facilitators related to mammography were identified, including the need to address cost/low cost (“screenings are a luxury”); prior negative/positive experiences (“they would call my name and look at me but dismiss me”); absence/presence of education (“none of the doctors…ever told me what that process looks like”); and perceived low/high cancer risk (“my mom died pretty young from breast cancer”). Finally, practical recommendations were offered, including individual changing/waiting rooms, hiring gender-diverse staff, and engaging clinicians who provide whole-person, trauma-informed care. Conclusions: Mammographic screening among TGD individuals could be improved by proactively creating safe, affirming spaces; working to lower costs; providing educational materials tailored to the TGD community about cancer risk and the practical aspects of screening; and hiring gender-diverse staff. These recommendations from TGD participants merit implementation as well as further study.
The Use of a Handheld Non-Invasive Vagal Nerve Stimulation (nVNS) Device for the Treatment of Long COVID: A Pilot Randomized Controlled Trial
Ganesh, Ravindra , Yadav, Siddhant, Croghan, Ivana T. , Hanson, Jennifer, Erickson, Megan, Fokken, Shawn, Seegmiller, Sara, Grach, Stephanie L. , Gilman, Elizabeth A. , Mueller, Michael , Croghan, Ivana T , Grach, Stephanie L , Gilman, Elizabeth A , Hurt, Ryan T. , Mueller, Michael R , Ganesh, Ravindra , Fokken, Shawn C. , Schroeder, Darrell R. , Hanson, Jennifer L., Seegmiller, Sara

Mayo Clinic

Journal of Primary Care & Community Health | July 25, 2026 | Volume: 17 | Issue: No issue available | Pages: No page available

10.1177/21501319261473073 | PMID 42501005 Get It

Objectives Long-term symptoms following infection with acute respiratory syndrome coronavirus-2 (SARS-CoV-2), termed post-acute sequelae of SARS-CoV-2 infection (PASC) or Long COVID (LC), persist beyond 90 days and may impact at least 10% of patients with acute infection. The exact cause of LC remains unknown, but several theories include persistent viral particles, immune dysfunction, and autonomic nervous system (ANS) imbalance, particularly involving the vagus nerve. Given the role of the vagus nerve in inflammation regulation, vagal nerve stimulation (VNS) is being explored as a treatment option. The present study aimed to evaluate the feasibility, safety, and exploratory effects of a handheld external transcutaneous cervical non-invasive VNS (tcVNS) on the primary endpoint of Post-COVID Functional Status (PCFS) grade, alongside secondary outcomes such as LC-related fatigue and other symptoms. Methods Participants from our Post COVID Care Clinic were randomized into treatment (tcVNS treatments two minutes, three times a day) and control (no VNS) groups for a study period of 12 weeks. Participants completed validated questionnaires, PET-CT scans, and inflammatory cytokines at baseline and 12 weeks. Results All randomized patients (8 tcVNS, 10 control) completed the 12-week study. Participants randomized to tcVNS were observed to have improvements in PHQ-9, PROMIS-F, and COMPASS-31 when compared to controls, but these differences were not statistically significant. Cortisol and DHEA were also observed to increase less in the tcVNS group when compared to the control group, but these changes were also not statistically significant. Conclusions tcVNS was well tolerated and may be a promising therapeutic approach for LC, a chronic disease with no approved treatments and very low rates of complete recovery.
Impact of faculty and resident gender on milestone evaluations in anesthesiology residency: a retrospective analysis
Martin, Yvette N. , Rose, Steven H., Gali, Bhargavi , Martin McGrew, Yvette , Schroeder, Darrell R.

Mayo Clinic

Medical Education Online | July 10, 2026 | Volume: 31 | Issue: 1 | Pages: No page available

10.1080/10872981.2026.2688660 | PMID 42429203 Get It

Patient Perspectives on an Autonomous Wheelchair Transport Pilot in a Tertiary Medical Center: A Cross-Sectional Survey
Hurt, Stephanie Decker, Bowman, Jon E., Schroeder, Darrell R. , Croghan, Ivana T. , Schroeder, Darrell , Croghan, Ivana T , Varayil, Jithinraj Edakkanambeth , Fischer, Karen M.

Mayo Clinic

Journal of Primary Care & Community Health | July 4, 2026 | Volume: 17 | Issue: No issue available | Pages: No page available

10.1177/21501319261463381 | PMID 42400404 Get It

Objective To evaluate patient satisfaction with the experience of using an autonomous wheelchair to transport patients in a large outpatient clinical environment. Methods The autonomous wheelchair pilot was approved as a feasibility pilot by the institutional committees and deemed a quality improvement project by the Institutional Review Board (IRB). A total of 409 adult patients using an autonomous wheelchair at a large academic medical center who volunteered to complete a paper survey were included. The survey was administered immediately after autonomous wheelchair use, using a cross-sectional, anonymous survey, between 15 Oct 2025 and 14 Jan 2026. Of 409 completed surveys, six were excluded because participants did not identify their endpoint for stratification purposes. Descriptive analysis included frequencies and percentages of responses. Results No collisions or adverse events were observed during the pilot, and the system operated reliably within the predefined routes. Most survey respondents were first-time users (335/402 [83.3%]). A majority reported they would use the autonomous wheelchair again (341/395 [86.3%]) and would recommend it to others (364/397 [91.7%]). Overall, the experience was rated better than expected by 293 of 393 participants (74.6%). When given a choice, 271 of 379 respondents (71.5%) preferred the autonomous wheelchair over a staff-operated wheelchair. Conclusion These findings suggest that autonomous wheelchairs are feasible and acceptable to patients in a controlled outpatient setting and support continued piloting and prospective evaluation.
Menopause and Its Implications for Stroke in Women
Thurston, Rebecca C. , Spicuzza, Jocelyn M. Delgado , Schroeder, Rachel A. , Mak, Elijah , Miller, Eliza C. , Kantarci, Kajal, Spicuzza, Jocelyn M , Mak, Elijah , Kantarci, Kejal

Mayo Clinic

Stroke | June 24, 2026 | Volume: 57 | Issue: 8 | Pages: 2531-2541

10.1161/strokeaha.126.052889 | PMID 42339545 Get It

Stroke is the third leading cause of death in women and a major driver of disability. Menopause is a universal transition for midlife women, which is accompanied by menstrual cycle changes, hormonal fluctuations, and, for many women, the occurrence of menopausal symptoms. An accumulating body of research underscores the importance of menopause and its features to stroke risk in women, including the type and timing of menopause, endogenous hormone profiles, and menopausal symptoms, including vasomotor symptoms and sleep problems. In addition, menopausal hormone therapy, a leading approach to managing menopausal symptoms, has implications for stroke risk, which varies depending on the menopausal hormone therapy formulation, route of delivery, and the age and health of the recipient, with transdermal menopausal hormone therapy formulations administered to younger midlife women showing a more favorable profile. This review summarizes the data linking menopause and stroke, and offers suggestions to inform clinical decision-making. Knowledge gaps and directions for future research are highlighted.
Current State and Needs of Clinical Laboratories in Selected Countries in Africa
Tesfazghi, Merih, Tebo, Anne E. , Harb, Roa , Okorodudu, Anthony O. , Schroeder, L, Guarner, Jeannette , Bales, Christine, Ladenson, Jack, Targowski, Allison, Cosby, Kerry, Oladipo, Olajumoke, Tesfazghi, Merih T. , Ladenson, Jack H., Oladipo, Olajumoke O.

Mayo Clinic

The Journal of Applied Laboratory Medicine | May 31, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1093/jalm/jfag089 | PMID 42335177 Get It

Abstract The Africa Working Group, under the auspices of the Global Laboratory Quality Initiative of the Association for Diagnostics & Laboratory Medicine (ADLM), conducted several educational workshops in Africa to promote laboratory quality in the region. The challenges faced in maintaining quality in clinical laboratories in low-resource countries may differ from region to region and country to country. To better understand current gaps and inform our engagement with partners in Africa, a needs assessment survey was distributed to 1427 ADLM members in Africa and further disseminated through local partners, resulting in 121 responses from participants across 8 countries in the region. Additionally, interviews were conducted with laboratory professionals from the countries surveyed. The surveys primarily focused on quality management, continuing education, budgeting, infrastructure and funding, supplies, and staffing issues. The data collected from the surveys and interviews strongly indicate that respondents face major challenges in all areas assessed, including lack of funding, lack of equipment, lack of quality control (QC) and external quality assessment (EQA) materials, gaps in quality management, lack of appropriate budgeting, staffing issues, and lack of accessible training/continuing education. Consistent with the primary focus of ADLM;s Global Quality Initiative, improved access to continuing education was identified as the primary need by the participants (58%). The assessment highlights that while a strong role for educational workshops in mitigating some of the challenges continues to exist, there is also an opportunity to broaden the scope of the working groups beyond education.
Early Postanesthesia Recovery Room Markers Associated With Delayed Respiratory Depression
Deljou, Atousa , Ghafouri, Kimia , Sprung, Juraj, Šprung, Juraj , Schroeder, Darrell R. , Weingarten, Toby N.

Mayo Clinic

The American Surgeon™ | May 23, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1177/00031348261455090 | PMID 42175723 Get It

Background Postoperative respiratory depression (PRD) is potentially preventable yet remains difficult to preemptively detect. We evaluated whether three post anesthesia care unit (PACU) events—oversedation, caffeine administration for impaired arousal, and naloxone administration—can serve as early markers of delayed PRD requiring naloxone administration on wards. Methods We retrospectively identified patients who underwent general anesthesia between 2018 and 2023 at a quaternary care academic medical center. From electronic medical records, we retrieved PACU naloxone and caffeine treatments, scores of sedation assessments using the Richmond Agitation-Sedation Scale (RASS), and ward naloxone administrations within 24 hours after PACU discharge. Results Among 95 870 patients, 186 (0.19%, 95% CI 0.17-0.22) required naloxone for respiratory depression after PACU discharge. Ward naloxone administration was independently associated with naloxone (OR 9.11, 95% CI 4.69-17.71, P < 0.001) and caffeine (OR 2.00, 95% CI 1.21-3.32, P = 0.007) administrations, and with PACU RASS scores ≤ −3 (OR 2.16, 95% CI 1.56-2.99, P < 0.001). Conclusions Naloxone administration in PACU was the strongest predictor of delayed PRD, followed by oversedation and PACU caffeine administration, indicating that information routinely collected during PACU recovery may offer insight into delayed respiratory risk before transition to hospital wards. In light of the overall low incidence of ward naloxone use, these findings support selective, risk-based vigilance for patients exhibiting these PACU events rather than broad adjustments to existing monitoring practices.
E-cigarette use in vehicles: factors associated with secondhand exposure and behaviour from a US young adult sample in 2024
Elizabeth, K. , Watkins, Joslynn A., Iskra, Madison L. , Koris, Kristiann , Graham, Amanda L. , Soule, Eric K. , Hair, Elizabeth C. , Do, Elizabeth K , Graham, Amanda L , Soule, Eric K , Hair, Elizabeth C , Cha, Sarah

Mayo Clinic

Tobacco Control | May 5, 2026 | Volume: No volume available | Issue: No issue available | Pages: tc-2025-059919

10.1136/tc-2025-059919 | PMID 42086323 Get It

Background This study investigates factors associated with electronic cigarette (e-cigarette) use and secondhand exposure in vehicles among US youth and young adults. Methods Data were collected from an online panel survey of individuals (N=3482, aged 15–25 years) from July to December 2024. Analyses included those who reported using any tobacco product in the past 30 days and answered items measuring exposure to (N=2600) and/or use of e-cigarettes in vehicles (N=2366). Logistic regression models assessed predictors of e-cigarette use and exposure in vehicles, including demographic, psychosocial and tobacco use characteristics. Results Among all participants, 67.1% reported e-cigarette use in the past 30 days. Of those reporting current e-cigarette use (N=2336), 60.6% reported using their e-cigarette/vape while travelling by car in the past 30 days. Of those who answered the question measuring exposure to e-cigarette use in vehicles (N=2600), 69.3% reported being in a vehicle where someone was using e-cigarettes. Higher nicotine dependence and residence in small metro and non-metro areas were associated with greater odds of using e-cigarettes in vehicles. Just meeting basic expenses or meeting needs with a little left, household tobacco use and residence in small metro areas were associated with greater odds of secondhand e-cigarette exposure. Discussion Public health interventions should place a strong focus on education and increasing public awareness of the health consequences of e-cigarette use in vehicles to protect bystanders from secondhand e-cigarette exposure.
Patient Perspectives on Point-of-Care Ultrasound Examinations in Consultative Outpatient Internal Medicine Practice
Overgaard, Joshua , Thilagar, Bright P. , Bhuiyan, M Nadir , Schroeder, Darrell R. , Fokken, Shawn C. , Fratianni, Amy M, Croghan, Ivana T. , Bhuiyan, Mohammed Nadir , Thilagar, Bright , Fokken, Shawn, Schroeder, Darrell , Fratianni, Amy M.

Mayo Clinic

Journal of Primary Care & Community Health | April 30, 2026 | Volume: 17 | Issue: No issue available | Pages: No page available

10.1177/21501319261447343 | PMID 42060782 Get It

Purpose While the clinical utility for Point-of-Care Ultrasound (POCUS) is well-established through its use in clinical practice to enhance diagnostic accuracy, expedite care, and improve patient interactions/communication, its impact on patient experience in outpatient consultative settings remains largely underexplored. We sought to evaluate patients’ experience and satisfaction by incorporating POCUS use during outpatient consultations. Methods In this prospective, cross-sectional survey study conducted in a consultative outpatient internal medicine practice, a continuous sample of 100 patients undergoing POCUS during routine medical evaluations participated. We assessed patient perspectives using a survey that was adapted from validated instruments. The following items were evaluated using the anonymized survey: the extent of patient understanding, the integration of POCUS into the consultation, its impact on patient-doctor communication, perceived quality of care, and overall patient experience. Results Most respondents felt better informed about their health (88%), more thoroughly examined (94%), and reported improved confidence in their physician’s assessment (92%) after the POCUS exam. In addition, POCUS was perceived as a natural part of the consultation (95%) and minimally burdensome (93%). Overall, 96% of study respondents agreed that POCUS improved their quality of care, and 98% described their experience as positive or very positive. Open-ended comments emphasized the immediacy of results, enhanced communication, and cost-effectiveness of the POCUS experience. Conclusion Incorporating POCUS in this environment improved patients’ perceptions of their physician, clinic, and overall care. These findings support the broader adoption of POCUS in similar clinical settings and its potential impact on healthcare delivery and patient satisfaction.
Methylene Blue Mouthwash for Oral Mucositis Pain in Cancer: An Open-Label, Non-Randomized Study
Karow, Jordan, Mackey, Regina M. , Olson, Emily, Wiste, Rachel, Siegel, Leslie R. , Strand, Jacob, Siegel, Leslie , Karow, Jordan C., Olson, Emily M. , Schroeder, Darrell R. , Lapid, Maria I.

Mayo Clinic

Journal of Pain & Palliative Care Pharmacotherapy | April 11, 2026 | Volume: 40 | Issue: 2 | Pages: 230-236

10.1080/15360288.2026.2655779 | PMID 41964386 Get It